{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:37:45Z","timestamp":1787319465164,"version":"build-2736575974"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T00:00:00Z","timestamp":1364947200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060479","type":"journal-article","created":{"date-parts":[[2013,4,3]],"date-time":"2013-04-03T23:25:01Z","timestamp":1365031501000},"page":"e60479","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Haptoglobin Phenotype, Preeclampsia Risk and the Efficacy of Vitamin C and E Supplementation to Prevent Preeclampsia in a Racially Diverse Population"],"prefix":"10.1371","volume":"8","author":[{"given":"Tracey L.","family":"Weissgerber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin E.","family":"Gandley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula L.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Y.","family":"Spong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Myatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Leveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Peaceman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Ramin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall W.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Sciscione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoram","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,3]]},"reference":[{"key":"ref1","first-page":"24","article-title":"Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group","volume":"95","author":"JC Hauth","year":"2000","journal-title":"Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0020-7292(98)00024-1","article-title":"Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders","volume":"61","author":"M Knuist","year":"1998","journal-title":"Int J Gynaecol Obstet"},{"key":"ref3","unstructured":"World Health Organization (2005) World Health Report: Make Every Mother, and Child Count. Geneva: WHO."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"D Altman","year":"2002","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"SE Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1067\/mob.2002.122969","article-title":"A longitudinal study of biochemical variables in women at risk of preeclampsia","volume":"187","author":"LC Chappell","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/OGX.0b013e3181bea0ac","article-title":"Lipid peroxidation and antioxidant status in preeclampsia: a systematic review","volume":"64","author":"S Gupta","year":"2009","journal-title":"Obstet Gynecol Surv"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)08016-2","article-title":"Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial","volume":"354","author":"LC Chappell","year":"1999","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1471-0528.2009.02158.x","article-title":"World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries","volume":"116","author":"J Villar","year":"2009","journal-title":"BJOG"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajog.2004.09.005","article-title":"Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial","volume":"192","author":"D Beazley","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(06)68433-X","article-title":"Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP Trial): randomised placebo-controlled trial","volume":"367","author":"L Poston","year":"2006","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.AOG.0000289576.43441.1f","article-title":"Antioxidant therapy to prevent preeclampsia: a randomized controlled trial","volume":"110","year":"2007","journal-title":"Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, <etal>et al<\/etal>.. (2010) An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 202: 239 e231\u2013239 e210.","DOI":"10.1016\/j.ajog.2010.01.050"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJMoa0908056","article-title":"Vitamins C and E to prevent complications of pregnancy-associated hypertension","volume":"362","author":"JM Roberts","year":"2010","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa054186","article-title":"Vitamins C and E and the risks of preeclampsia and perinatal complications","volume":"354","author":"AR Rumbold","year":"2006","journal-title":"N Engl J Med"},{"key":"ref16","first-page":"293","article-title":"Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, et al. Haptoglobin: basic and clinical aspects","volume":"12","journal-title":"Antioxid Redox Signal"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1172\/JCI116319","article-title":"Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis","volume":"91","author":"MC Cid","year":"1993","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2337\/diacare.27.11.2767","article-title":"The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes","volume":"27","author":"AP Levy","year":"2004","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/ATVBAHA.107.153965","article-title":"Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2\u20132 genotype: a prospective double-blinded clinical trial","volume":"28","author":"U Milman","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2217\/pgs.10.17","article-title":"Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2\u20132 genotype","volume":"11","author":"S Blum","year":"2010","journal-title":"Pharmacogenomics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.27.4.925","article-title":"The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women","volume":"27","author":"AP Levy","year":"2004","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/ars.2009.2793","article-title":"Haptoglobin: basic and clinical aspects","volume":"12","author":"AP Levy","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/clinchem\/42.10.1589","article-title":"Biological and clinical significance of haptoglobin polymorphism in humans","volume":"42","author":"MR Langlois","year":"1996","journal-title":"Clin Chem"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Weissgerber TL, Roberts JM, Jeyabalan A, Powers RW, Lee M, <etal>et al<\/etal>.. (2012) Haptoglobin phenotype, angiogenic factors, and preeclampsia risk. Am J Obstet Gynecol 206: 358 e310\u2013318.","DOI":"10.1016\/j.ajog.2012.01.009"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1520\/JFS11232J","article-title":"Distributions of genetic markers in United States populations: III. Serum group systems and hemoglobin variants","volume":"32","author":"RE Gaensslen","year":"1987","journal-title":"J Forensic Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/ATVBAHA.107.159905","article-title":"Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2\u20132 genotype","volume":"28","author":"S Blum","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2010.02.018","article-title":"The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes","volume":"211","author":"S Blum","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.2337\/db08-0450","article-title":"Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2\u20132 genotype","volume":"57","author":"R Asleh","year":"2008","journal-title":"Diabetes"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2307\/2529548","article-title":"Efficiency of Case-Control Studies with Multiple Controls Per Case: Continuous or Dichotomous Data","volume":"31","author":"HK Ury","year":"1975","journal-title":"Biometrics"},{"key":"ref30","unstructured":"Weissgerber TL, Gandley RE, Roberts JM, Patterson CC, Holmes VA, et al. (in review) Haptoglobin phenotype and preeclampsia incidence in women with Type 1 Diabetes supplemented with Vitamins C and E."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/aje\/kwh079","article-title":"Relation of ascorbic acid to coronary artery calcium: the Coronary Artery Risk Development in Young Adults Study","volume":"159","author":"JA Simon","year":"2004","journal-title":"Am J Epidemiol"},{"key":"ref32","unstructured":"Lumey Thomas (2010) Complex surveys: A guide to analysis using R. Hoboken, NJ: John Wiley &amp; Sons."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/01621459.1981.10477633","article-title":"The analysis of categorical data from complex sample surveys: chi-squared tests for goodness-of-fit and independence in two-way tables","volume":"76","author":"JNK Rao","year":"1981","journal-title":"Journal of the American Statistical Association"},{"key":"ref34","unstructured":"Siegel Castellan (1988) Non parametric statistics for the behavioural sciences. New York: McGraw Hill Int."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3945\/ajcn.2010.29306","article-title":"Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency","volume":"92","author":"LE Cahill","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1515\/CCLM.2006.182","article-title":"Haptoglobin polymorphism in patients with preeclampsia","volume":"44","author":"HT Depypere","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12020-010-9392-7","article-title":"Haptoglobin phenotype in women with preeclampsia","volume":"38","author":"RN Sammour","year":"2010","journal-title":"Endocrine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/jmg.40.3.214","article-title":"Haptoglobin and its association with the HELLP syndrome","volume":"40","author":"MT Raijmakers","year":"2003","journal-title":"J Med Genet"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4236\/abb.2012.327126","article-title":"Involvement of haptoglobin in prevention of oxidative stress caused by hemoglobin in preeclampsia","volume":"3","author":"H Goldenstein","year":"2012","journal-title":"Advances in Bioscience and Biotechnology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/plac.2002.0819","article-title":"Recent Insights into the pathogenesis of pre-eclampsia","volume":"23","author":"JM Roberts","year":"2002","journal-title":"Placenta"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2011.02.005","article-title":"Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association","volume":"57","author":"L Mosca","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/AOG.0b013e31823974e2","article-title":"Gestational diabetes mellitus","volume":"118","author":"MB Landon","year":"2011","journal-title":"Obstet Gynecol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2393-12-23","article-title":"Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria","volume":"12","author":"EM Wendland","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2337\/dc09-1219","article-title":"Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study","volume":"33","author":"DM Jensen","year":"2010","journal-title":"Diabetes Care"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"163","author":"YW Park","year":"2003","journal-title":"Archives of internal medicine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/AOG.0b013e3182571669","article-title":"First-trimester prediction of preeclampsia in nulliparous women at low risk","volume":"119","author":"L Myatt","year":"2012","journal-title":"Obstetrics and gynecology"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev: CD007176.","DOI":"10.1002\/14651858.CD007176"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"S Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.288.19.2432","article-title":"Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial","volume":"288","author":"DD Waters","year":"2002","journal-title":"JAMA"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:21:18Z","timestamp":1715145678000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060479"}},"subtitle":[],"editor":[{"given":"Cees","family":"Oudejans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,3]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060479","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,3]]}}}